Belvedere Trading LLC

Position in CUE — Cue Biopharma, Inc.

CIK 1632341 CHICAGO, IL

Back to CUE Full portfolio

Position in CUE

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

-$224,152 QoQ

Shares Held

-100.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

4 quarters on record

Common Shares in CUE Over Time

Shares Held

Position Value (USD)

Derivatives in CUE

reported options exposure · as of Jun 30, 2026

CallValue

$1,101,444

CallShares

34,900

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Belvedere Trading LLC holds $401,074 across 2 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)	Open
1	ORKA	Oruka Therapeutics, Inc.	3,531	$336,045
2	OTLK	Outlook Therapeutics, Inc.	40,899	$65,029

All Filings in CUE

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,101,444	34,900	—	Call	Sole	2026-07-31
2021-12-31	$224,152	19,819	+113.2%	Shares	Sole	2022-01-25
2021-03-31	$113,435	9,298	+159.8%	Shares	Sole	2021-04-27
2021-03-31	$276,939	22,700	-2.2%	Put	Sole	2021-04-27
2020-12-31	$290,231	23,200	—	Put	Sole	2021-02-10
2020-12-31	$44,773	3,579	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.